Cited by 65Thyroid Disorders and TreatmentsSelenium in Biological SystemsThyroid and Parathyroid Surgery

Selenium supplementation for Hashimoto's thyroiditis: summary of a Cochrane systematic review

Open access
van Zuuren, Esther J., Albusta, Amira Y., Fedorowicz, Zbys, Carter, Ben, Pijl, Hanno·2014·European Thyroid Journal

Abstract

Selenium supplementation in people with Hashimoto's thyroiditis might reduce antibody levels and result in a decreased dosage of levothyroxine (LT4) and may provide other beneficial effects (e.g. on mood and health-related quality of life). The aim of our systematic review was to assess the effects of selenium supplementation on Hashimoto's thyroiditis. We searched The Cochrane Library, MEDLINE, EMBASE and Web of Science for randomized controlled trials. Study selection, data extraction, assessment of risk of bias and analyses were carried out by two independent review authors. We assessed the quality of the evidence of included studies using GRADE. Four studies rated at unclear to high risk of bias comprising 463 participants were included. One study at high risk of bias showed statistically significant improvement in subjective well-being with sodium selenite 200 μg plus titrated LT4 compared with placebo plus titrated LT4 (RR 4.67, 95% CI 1.61-13.50). Selenomethionine 200 μg as a single treatment or combined with LT4 reduced the serum levels of anti-thyroid peroxidase antibodies compared with placebo (or placebo plus LT4) in three studies (p < 0.001). Although the changes from baseline were statistically significant in these three studies, their clinical relevance is unclear. In conclusion, the results of these four studies, assessed at unclear to high risk of bias, show that evidence to support or refute the efficacy of selenium supplementation in people with Hashimoto's thyroiditis is incomplete and not reliable to help inform clinical decision making.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000356040

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Selenium might have a role in reducing TPO-Ab concentrations, although results and potential benefits from selenium supplementation studies have been inconsistent.

    “Selenium might have a role in reducing TPO-Ab concentrations, 168,169 although results and potential benefits from selenium supplementation studies have been inconsistent.170”

    From Hypothyroidism (2024) · cites this paper as [170]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Fink H, Hintze G: Autoimmune thyroiditis (Hashimoto's thyroiditis): current diagnos- tics and therapy. Med Klin 2010; 105: 485-493.
  2. Stathatos N, Daniels GH: Autoimmune thy- roid disease. Curr Opin Rheumatol 2012; 24: 70-75.

Cited by

Sorted by citations

Authors
van Zuuren, E. J., Albusta, A. Y., Fedorowicz, Z., Carter, B., & Pijl, H.
Affiliations
  • 1
  • University of Technology Bahrain (BH)
  • Cochrane Canada (CA)
  • 5
  • Leiden University Medical Center (NL)
Venue
European Thyroid Journal
Published
2013-11-21
Volume
3
Issue
1
Pages
25-31
ISSN
  • 2235-0640 (ISSN-L)
  • 2235-0802
OpenAlex
W2035024811
Cited by
65
References
22
Citations by year
2026: 3 · 2025: 7 · 2024: 7 · 2023: 2 · 2022: 7 · 2021: 2 · 2020: 3 · 2019: 9 · 2018: 6 · 2017: 7 · 2016: 5 · 2015: 7
FWCI
0.59
Type
journal article
Language
en
Open access
Locations
  • European Thyroid Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Nursing › Nutrition and Dietetics › Selenium in Biological Systems
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
Keywords
selenium supplementation, Hashimoto's thyroiditis, autoimmune thyroid disease, thyroid peroxidase antibodies, levothyroxine, selenomethionine, sodium selenite, health-related quality of life, mood, risk of bias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review